TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Sever Pharma Solutions AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
642,050
|
576,917
|
466,021 |
Financial expenses |
5,584
|
5,452
|
3,903 |
Earnings before taxes |
-23,859
|
15,971
|
27,269 |
EBITDA |
8,266
|
42,243
|
47,601 |
Total assets |
645,328
|
517,388
|
444,413 |
Current assets |
350,105
|
264,115
|
192,262 |
Current liabilities |
220,145
|
183,255
|
91,935 |
Equity capital |
407,401
|
312,768
|
221,967 |
- share capital |
10,130
|
9,459
|
9,752 |
Employees (average) |
322
|
312
|
278 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
63.1%
|
60.5%
|
49.9% |
Turnover per employee |
1,994
|
1,849
|
1,676 |
Profit as a percentage of turnover |
-3.7%
|
2.8%
|
5.9% |
Return on assets (ROA) |
-2.8%
|
4.1%
|
7.0% |
Current ratio |
159.0%
|
144.1%
|
209.1% |
Return on equity (ROE) |
-5.9%
|
5.1%
|
12.3% |
Change turnover |
24,197
|
124,902
|
36,512 |
Change turnover % |
4%
|
28%
|
9% |
Chg. No. of employees |
10
|
34
|
22 |
Chg. No. of employees % |
3%
|
12%
|
9% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.